drugset / Trial / NCT04183634
An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study is to evaluate the adhesion of the test product when compared to the reference product following a single transdermal application.
Timeline
- Start
- 2019-12-03
- Primary completion
- 2020-03-16
- Completion
- 2020-03-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rotigotine | Unknown | 18 mg | Other |